medigraphic.com
ISSN 2007-3194 (Print)
Órgano de difusión oficial del Instituto Materno Infantil del Estado de México

2015, Number 1

<< Back Next >>

Arch Inv Mat Inf 2015; 7 (1)

Ebola

Valles LA, Aguirre BZY, Garcilazo RA, Esquivel MJE, Manjarrez GRM, Álvarez MGD, Gutiérrez GVM

Language: Spanish
References: 15
Page: 21-26
PDF size: 154.28 Kb.


ABSTRACT

Ebola virus disease (EVE) is the prototype of hemorrhagic fevers, with high importance within public health and representing an entity that develops as a serious disease with a high fatality rate. In infected humans, it usually presents initially with general symptoms (such as fever, vomiting and severe diarrhea), and less than half of those infected show visible hemorrhagic symptoms. The current outbreak is the largest in history, with 20 206 reported cases and 7 904 deaths until December 31st, 2014, a fatality rate of 39.12%, and nine countries involved. In this article we review the issue and analyze the current outbreak.


REFERENCES

  1. Feldmann H. Ebola –a growing threat?, N Engl J Med, 2014; 371: 1375-1378.

  2. Feldmann H, Geisbert TW. Ebola haemorrhagic fever, Lancet, 2011; 377 (9768): 849-862.

  3. Kuhn JH, Becker S, Ebihara H, Geisbert TW, Johnson KM, Kawaoka Y et al. Proposal for a revised taxonomy of the family Filoviridae: classification, names of taxa and viruses, and virus abbreviations, Arch Virol, 2010; 155 (12): 2083-2103.

  4. Baize S, Pannetier D, Oestereich L, Rieger T, Saliou SM, Keïta S et al. Emergence of Zaire Ebola virus disease in Guinea, N Engl J Med, 2014; 371: 1418-1425.

  5. WHO Ebola Response Team. Ebola virus disease in West Africa –the first 9 months of the epidemic and forwards projections, N Engl J Med, 2014; 371: 1481-1495.

  6. Swanepoel R, Leman PA, Burt FJ, Zachariades NA, Braack LEO, Ksiazek TG et al. Experimental inoculation of plants and animals with Ebola virus, Emerg Infect Dis, 1996; 2 (4): 321-325.

  7. Towner JS, Amman BR, Sealy TK, Reeder CSA, Comer JA, Kemp A et al. Isolation of genetically diverse Marburg viruses from Egyptian fruit bats, PLoS Pathogens, 2009 5 (7): 1-9.

  8. Lamontagne F, Clément C, Fletcher T, Jacob ST, Fischer WA, Fowler RA. Doing today’s work superbly well –treating Ebola with current tools, N Engl J Med, 2014; 371: 1565-1566.

  9. Goodman JL. Studying “secrets serums”–toward safe, effective Ebola treatments, N Engl J Med, 2014; 371: 1086-1089.

  10. World Health Organization. Use of convalescent whole blood or plasma collected from patients recovered from Ebola virus disease for transfusion, as an empirical treatment during outbreaks, WHO/HIS/SDS/2014.8. 2014; pp. 4-19.

  11. World Health Organization. Interim infection prevention and control guidance for care of patients with suspected or confirmed filovirus haemorrhagic fever in health-care settings, with focus on Ebola, WHO/HIS/SDS/2014.4 Rev.1. 2014; pp. 6-18.

  12. Centers for Disease Control and Prevention. Guidance for Safe Handling of Human Remains of Ebola Patients in US Hospitals and Mortuaries, CDC 2014 [última actualización 23 de octubre de 2014]; [consultado el 27 de octubre de 2014]. Disponible en: http://www.cdc.gov/vhf/ebola/hcp/guidance-safe-handling-human-remains-ebola-patients-us-hospitals-mortuaries.html

  13. Kanapathipillai R, Restrepo AMH, Fast P, Wood D, Dye C, Kieny MP et al. Ebola vaccine-an urgent international priority, N Engl J Med, 2014; 371: 2249-2251.

  14. World Health Organization. Enfermedad por virus del Ébola. Nota descriptiva No. 103, Abril 2014. Disponible en: http://www.who.int/mediacentre/factsheets/fs103/es/

  15. World Health Organization. Ebola response roadmap situation report, 31 December 2014; WHO 2014; 1-16. Disponible en: http://apps.who.int/iris/bitstream/10665/146763/1/roadmapsitrep_31Dec14_eng.pdf?ua=1&ua=1




2020     |     www.medigraphic.com